Enlarged cancer cell nuclei may limit spread rather than signal severity

In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) that are ...
The Scientist

A Technology that Scales Up Whole Transcriptome Single-Cell Analysis

The Evercode™ WT Penta is recognized in the 2025 Top Innovations contest’s Lab Research Tools category.

AI-Driven Micro-Analytics for Drug, Agriculture, Food, Beverage and Cosmetics Development

Athos Therapeutics launches a new AI platform, Athos Omics AI, to provide no-code, micro-analytics for drug, food, and ...
ascopubs.org

Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non–Small Cell Lung Cancer

Functional Characterization of Variants of Unknown Significance of Fibroblast Growth Factor Receptors 1-4 and Comparison With AI Model–Based Prediction An economic model was developed to estimate the ...

Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
AZoLifeSciences on MSN

Microarray Profiling Identifies LINC00974 as a Sensitive Marker for Breast Cancer Risk

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers.